The approval marks the second international approval for rozanolixizumab (Rystiggo; UCB Pharma) for generalized myasthenia ...

Pelvic floor disorders affect roughly one in three women in the United States, leading many to suffer from a variety of ...

For female patients with MS, transcutaneous posterior tibial nerve stimulation and repetitive transcranial magnetic stimulation are comparable for neurogenic overactive bladder symptoms.